Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
NRC National Research Corp
- Stocks
- Healthcare
- NASDAQ: NRC
Price (delayed)
$13.42
Market cap
$307.93M
P/E Ratio
12.78
Dividend/share
$0.48
EPS
$1.05
Enterprise value
$366.38M
NRC Health is the leading provider of in-depth customer insights in healthcare.
Highlights
The stock's price to earnings (P/E) is 58% less than its 5-year quarterly average of 29.8 and 43% less than its last 4 quarters average of 21.9
The quick ratio has grown by 30% since the previous quarter but it has declined by 19% year-on-year
National Research's debt has surged by 71% YoY and by 17% QoQ
National Research's equity has decreased by 36% YoY and by 10% QoQ
Key stats
What are the main financial stats of NRC
Market
Valuations
Earnings
Shares outstanding
22.95M
Market cap
$307.93M
Enterprise value
$366.38M
Price to earnings (P/E)
12.78
Price to book (P/B)
10.07
Price to sales (P/S)
2.22
EV/EBIT
10.38
EV/EBITDA
8.87
EV/Sales
2.56
Revenue
$143.06M
Gross profit
$86.13M
Operating income
$35.19M
Net income
$24.78M
EBIT
$35.29M
EBITDA
$41.31M
Free cash flow
$19.18M
Per share
Balance sheet
Liquidity
EPS
$1.05
EPS diluted
$1.04
Free cash flow per share
$0.81
Book value per share
$1.33
Revenue per share
$6.04
TBVPS
$2.69
Total assets
$132.54M
Total liabilities
$101.26M
Debt
$62.68M
Equity
$31.28M
Working capital
-$16.26M
Debt to equity
2
Current ratio
0.55
Quick ratio
0.43
Net debt/EBITDA
1.42
Margins
Efficiency
Dividend
EBITDA margin
28.9%
Gross margin
60.2%
Net margin
17.3%
Operating margin
24.6%
Return on assets
19.7%
Return on equity
69.3%
Return on invested capital
55%
Return on capital employed
36.5%
Return on sales
24.7%
Dividend yield
3.58%
DPS
$0.48
Payout ratio
45.7%
NRC stock price
How has the National Research stock price performed over time
Intraday
2.52%
1 week
10.77%
1 month
12.21%
1 year
-54.91%
YTD
-23.92%
QTD
4.84%
Financial performance
How have National Research's revenue and profit performed over time
Revenue
$143.06M
Gross profit
$86.13M
Operating income
$35.19M
Net income
$24.78M
Gross margin
60.2%
Net margin
17.3%
NRC's net income is down by 20% YoY and by 8% QoQ
National Research's net margin has decreased by 17% YoY and by 8% QoQ
NRC's operating income is down by 12% YoY and by 6% QoQ
National Research's operating margin has decreased by 9% YoY and by 5% QoQ
Price vs fundamentals
How does NRC's price correlate with its fundamentals
Growth
What is National Research's growth rate over time
Valuation
What is National Research stock price valuation
P/E
12.78
P/B
10.07
P/S
2.22
EV/EBIT
10.38
EV/EBITDA
8.87
EV/Sales
2.56
The stock's price to earnings (P/E) is 58% less than its 5-year quarterly average of 29.8 and 43% less than its last 4 quarters average of 21.9
The EPS has declined by 17% year-on-year and by 7% since the previous quarter
NRC's price to book (P/B) is 43% less than its last 4 quarters average of 17.1 and 41% less than its 5-year quarterly average of 16.7
National Research's equity has decreased by 36% YoY and by 10% QoQ
The P/S is 69% lower than the 5-year quarterly average of 6.9 and 48% lower than the last 4 quarters average of 4.2
National Research's revenue has decreased by 3.7% YoY
Efficiency
How efficient is National Research business performance
NRC's return on invested capital is down by 47% year-on-year and by 18% since the previous quarter
NRC's return on equity is up by 45% year-on-year and by 2.8% since the previous quarter
The return on assets has declined by 19% year-on-year and by 10% since the previous quarter
The return on sales has declined by 10% year-on-year and by 5% since the previous quarter
Dividends
What is NRC's dividend history
DPS
$0.48
Dividend yield
3.58%
Payout ratio
45.7%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did National Research financials performed over time
NRC's total assets is 31% greater than its total liabilities
National Research's total liabilities has increased by 38% YoY and by 4.2% QoQ
The quick ratio has grown by 30% since the previous quarter but it has declined by 19% year-on-year
National Research's debt is 100% higher than its equity
NRC's debt to equity has soared by 167% YoY and by 29% QoQ
National Research's debt has surged by 71% YoY and by 17% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.